Comparison

Trelagliptin succinate European Partner

Item no. TMO-T2296-200mg
Manufacturer TargetMol
CASRN 1029877-94-8
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles Cn1c(=O)cc(n(c1=O)Cc1c(ccc(c1)F)C#N)N1CCC[C@H](C1)N.C(CC(=O)O)C(=O)O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias SYR-472 succinate,SYR472
Shipping Condition Cool pack
Available
Manufacturer - Targets
Proteasome|||DPP-4
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
475.47
Description
Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
Pathways
Proteases/Proteasome|||Ubiquitination

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close